Robert A. Scott
CIK: 0001248520
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARQT
Arcutis Biotherapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About SCOTT ROBERT A
SCOTT ROBERT A (SEC CIK 0001248520) files insider reports with the SEC as Director of Arcutis Biotherapeutics, Inc. (ARQT).
Signal8 holds 2 ownership filings by SCOTT ROBERT A (1 Form 3, 1 Form 4), filed on Oct 28, 2026. Those filings report 1 transaction, the latest on Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SCOTT ROBERT A's filings is in WESTLAKE VILLAGE, CA.
Recent filings by SCOTT ROBERT A
- Oct 23, 2026: Grant or award of ARQT shares (Form 4, code A).
Other insiders filing for Arcutis Biotherapeutics, Inc. (ARQT)
- Welgus Howard G., Director
- Matsuda Masaru
- Curran Terrie, Director
- Burnett Patrick
- Watanabe Todd
- Peetz Christopher, Director